Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from barrett's esophagus

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 1059-1063

  Tomizawa, Yutaka ^a   Wu, Tsung Teh ^a   Wang, Kenneth K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Barrett's esophagus; Cancer stem cell; Epithelial mesenchymal transition; Esophageal adenocarcinoma

Indexed keywords

CD133 ANTIGEN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ARTICLE; BARRETT ESOPHAGUS; CANCER MORPHOLOGY; CANCER STEM CELL; CLINICAL ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TISSUE SECTION;

EID: 84863297392     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.632     Document Type: Article

References (35)

1. Pohl H and Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 19: 142-146, 2005.
2. Surveillance Epidemiology and End Results. http://seer.cancer.gov/csr/1975_2008/index.html. Updated November 2011.
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al: Hospital volume and surgical mortality in the United States. N Engl J Med 11: 1128-1137, 2002.
4. Liu L, Hofstetter W, Rashid A, et al: Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29: 1079-1085, 2005.
5. Guarino M: Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39: 2153-2160, 2007.
6. Natalwala A, Spychal R and Tselepis C: Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 14: 3792-3797, 2008.
7. Spaderna S, Schmalhofer O, Hlubek F, et al: A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131: 830-840, 2006.
8. Usami Y, Satake S, Nakayama F, et al: Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 215: 330-339, 2008.
9. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
10. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumors: accumulating evidence and unsolved questions. Nat Rev Cancer 8:755-768, 2008.
11. Mizrak D, Brittan M and Alison MR: CD133: molecule of the moment. J Pathol 214: 3-9, 2008.
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115, 2007.
13. Yin S, Li J, Hu C, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120: 1444-1450, 2007.
14. Prasad GA, Wu TT, Wigle DA, et al: Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 137: 815-823, 2009.
15. Jethwa P, Naqvi M, Hardy RG, et al: Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 14: 1044-1052, 2008.
16. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
17. Lagarde SM, ten Kate FJ, Reitsma JB, et al: Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24: 4347-4355, 2006.
18. Hahn HP, Shahsafaei A and Odze RD: Vascular and lymphatic properties of the superficial and deep lamina propria in Barrett esophagus. Am J Surg Pathol 32: 1454-1461, 2008.
19. Badreddine RJ, Prasad GA, Lewis JT, et al: Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol 8: 248-253, 2010.
20. Westerterp M, Koppert LB, Buskens CJ, et al: Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446: 497-504, 2005.
21. Washington K, Chiappori A, Hamilton K, et al: Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod Pathol 11: 805-813, 1998.
22. Oda T, Kanai Y, Oyama T, et al: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
23. Yang MH, Chen CL, Chau GY, et al: Comprehensive analysis of the independent effect of Twist and Snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474, 2009.
24. Lowy AM, Knight J and Groden J: Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis. Surgery 132: 141-148, 2002.
25. Cano A, Pérez-Moreno MA, Rodrigo I, et al: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.
26. Batlle E, Sancho E, Francí C, et al: The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
27. Vernon AE and LaBonne C: Tumor metastasis: a new twist on epithelial - mesenchymal transitions. Curr Biol 14: 719-721, 2004.
28. Castanon I and Baylies MK: A Twist in fate: evolutionary comparison of Twist structure and function. Gene 287: 11-22, 2002.
29. Natsugoe S, Uchikado Y, Okumura H, et al: Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 17: 517-523, 2007.
30. Yuen HF, Chan YP, Wong ML, et al: Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 60: 510-514, 2007.
31. Reya T, Morrison SJ, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
32. Nowell PC: The clonal evolution of tumor cell populations. Science 194: 23-28, 1976.
33. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007.
34. Brabletz T, Jung A, Spaderna S, et al: Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749, 2005.
35. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.